Cancer Extracellular Matrix Proteins Regulate Tumour Immunity
The extracellular matrix (ECM) plays an increasingly recognised role in the development and progression of cancer. Whilst significant progress has been made in targeting aspects of the tumour microenvironment such as tumour immunity and angiogenesis, there are no therapies that address the cancer EC...
Main Authors: | Alex Gordon-Weeks, Arseniy E. Yuzhalin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3331 |
Similar Items
-
Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients
by: Christina Jensen, et al.
Published: (2018-12-01) -
Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
by: Shaoli Das, et al.
Published: (2020-09-01) -
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
by: Muhammad Umair Mushtaq, et al.
Published: (2018-07-01) -
Cervical Cancer: Emerging Immune Landscape and Treatment
by: Guo L, et al.
Published: (2020-08-01) -
Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer
by: Ramiz S. Ahmad, et al.
Published: (2021-06-01)